Position in NAMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,669,827
-$13,785,288 QoQ
Shares Held
344,508
-56.7% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 198 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. NAMS ranks #106 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in NAMS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 NAMSW | $9,466 | 443 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $11,660,361 | 344,065 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 NAMSW | $7,935 | 396 | Shares | Defined | 2026-05-05 | |
| 2026-03-31 | $25,447,180 | 794,976 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 NAMSW | $9,108 | 396 | Shares | Defined | 2026-01-29 | |
| 2025-12-31 | $31,552,425 | 899,442 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 NAMSW | $8,760 | 512 | Shares | Defined | 2025-11-13 | |
| 2025-09-30 | $21,856,708 | 768,520 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 NAMSW | $7,944 | 993 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $11,367,989 | 627,719 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 NAMSW | $21,405 | 2,381 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $8,149,986 | 398,143 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 NAMSW | $35,354 | 2,481 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $2,061,396 | 80,210 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,161,983 | 130,240 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $116,584 | 6,069 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,141,797 | 48,279 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $8,936 | 800 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 NAMSW | $72 | 38 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,175 | 183 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 NAMSW | $933 | 1,076 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||